Insider Transactions in Q4 2021 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 07
2021
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
3,612
-14.07%
|
$21,672
$6.99 P/Share
|
Dec 07
2021
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,667
+36.37%
|
-
|
Dec 03
2021
|
Philip H Coelho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.55%
|
-
|
Dec 03
2021
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+33.33%
|
-
|
Dec 03
2021
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.58%
|
-
|
Dec 03
2021
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.22%
|
-
|
Dec 03
2021
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.43%
|
-
|
Dec 03
2021
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.56%
|
-
|
Dec 03
2021
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,571
-12.17%
|
-
|
Dec 03
2021
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,667
+33.33%
|
-
|
Dec 03
2021
|
Alicia Grande VP, Treasurer and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,571
-0.75%
|
-
|
Dec 03
2021
|
Alicia Grande VP, Treasurer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,667
+2.97%
|
-
|
Dec 03
2021
|
Patrick J Mcenany Director |
SELL
Payment of exercise price or tax liability
|
Direct |
12,132
-0.25%
|
-
|
Dec 03
2021
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,833
+0.62%
|
-
|